Does ZOLOFT Cause Maternal exposure timing unspecified? 19 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Maternal exposure timing unspecified have been filed in association with ZOLOFT. This represents 2.5% of all adverse event reports for ZOLOFT.
19
Reports of Maternal exposure timing unspecified with ZOLOFT
2.5%
of all ZOLOFT reports
2
Deaths
6
Hospitalizations
How Dangerous Is Maternal exposure timing unspecified From ZOLOFT?
Of the 19 reports, 2 (10.5%) resulted in death, 6 (31.6%) required hospitalization, and 4 (21.1%) were considered life-threatening.
Is Maternal exposure timing unspecified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ZOLOFT. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does ZOLOFT Cause?
Maternal exposure during pregnancy (162)
Drug hypersensitivity (116)
Congenital anomaly (69)
Drug ineffective (61)
Atrial septal defect (41)
Anxiety (38)
Premature baby (36)
Ventricular septal defect (34)
Patent ductus arteriosus (30)
Depression (29)
What Other Drugs Cause Maternal exposure timing unspecified?
RITUXIMAB (402)
METHOTREXATE (350)
ADALIMUMAB (343)
DICLOFENAC (331)
TOCILIZUMAB (327)
HYDROXYCHLOROQUINE (309)
FOLIC ACID (304)
INFLIXIMAB (303)
LEFLUNOMIDE (302)
SECUKINUMAB (301)
Which ZOLOFT Alternatives Have Lower Maternal exposure timing unspecified Risk?
ZOLOFT vs ZOLPIDEM
ZOLOFT vs ZOLPIDEM\ZOLPIDEM
ZOLOFT vs ZOMETA
ZOLOFT vs ZONISAMIDE
ZOLOFT vs ZOPICLONE